Speaker Bio
Ross Muken, B.Sc., is a seasoned executive with more than 20 years of experience across life sciences, health technology, medical devices, and pharma services. Ross joined SOPHiA GENETICS in February 2021 as Chief Financial Officer, and in March 2023 was appointed, Chief Financial Officer & Chief Operating Officer. In November 2024, Ross was appointed President.
Before joining SOPHiA GENETICS, he was CFO & COO of Click Therapeutics. Prior to that, he was partner, Senior Managing Director and head of the healthcare services & technology equity research team at Evercore/ISI Group, where he covered more than 50 companies across the healthcare technology & distribution, life science tools & diagnostics, managed care & facilities and medical supplies & devices subsectors.
Earlier in his career, Ross served as Senior Managing Director at Deutsche Bank Securities and was part of the equity research division at Thomas Weisel Partners. His professional journey began as an M&A investment banker at Bank of America Securities after graduating from Boston University magna cum laude with a B.Sc. in business administration.
Earlier in his career, Ross served as Senior Managing Director at Deutsche Bank Securities and was part of the equity research division at Thomas Weisel Partners. His professional journey began as an M&A investment banker at Bank of America Securities after graduating from Boston University magna cum laude with a B.Sc. in business administration.